Eurofins Scientific SE PDMR Transactions Notification
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 16 2026
0mins
Source: Businesswire
- Executive Trading Overview: Eurofins Scientific SE has received multiple transaction notifications from Persons Discharging Managerial Responsibilities (PDMR), involving its controlling company Analytical Bioventures S.C.A, indicating active trading behavior among company insiders that may influence market confidence in the stock.
- Transaction Details Disclosure: Between February 10 and 13, 2026, PDMR acquired a total of 4,000 shares at prices of €67.44, €66.21, €64.08, and €65.21, amounting to a cumulative transaction value of €265,000, reflecting management's confidence in the company's future prospects.
- Market Reaction Potential: The public disclosure of these transactions complies with European Market Abuse Regulation, which may attract investor attention to the company's stock, especially in the context of active insider buying, potentially leading to positive price movements.
- Company Background Information: Eurofins Scientific SE is a global leader in bio-analysis, employing over 65,000 staff across more than 950 laboratories, offering over 200,000 analytical methods, showcasing its strong capabilities and market position in the industry.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
